AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21450978
Drug: Nonadjuvanted H1N1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted H1N1 vaccine containing 15 μg HA
Trial: 21450978
Drug: Nonadjuvanted H1N1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonadjuvanted H1N1 vaccine containing 3.75 μg HA
Trial: 17892986
Drug: Subcutaneous erythropoietin
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous erythropoietin (EPO) for 4 months followed by maintenance for another 8 months, with oral iron throughout 12 months.
Trial: 17892986
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received saline as placebo and oral iron throughout 12 months.
Trial: 9773717
Drug: Implantable Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implantable Insulin Pump (IIP) therapy
Trial: 9773717
Drug: Multiple-Dose Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-Dose Insulin (MDI) therapy
Trial: 8148225
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate (100 mg elemental iron) with norfloxacin (400 mg)
Trial: 8148225
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate (100 mg elemental iron) with ciprofloxacin (500 mg)
Trial: 8148225
Drug: Ferrous sulphate
RxNorm normalized name: Ferrous sulphate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulphate (100 mg elemental iron) with ofloxacin (400 mg)
Trial: 3167505
Drug: Peritendonous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peritendonous injection of 40 mgs of methyl prednisolone acetate (Depo Medrone)
Trial: 3167505
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of 0.25% marcaine alone
Trial: 31874736
Drug: Goal Directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal Directed Fluid Therapy (GDFT) using non-invasive cardiac output monitoring for 12 hours
Trial: 29292264
Drug: Control (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (single anesthetic agent)
Trial: 25877225
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m² for level 1 and 1200 mg/m² for level 2 on day 1), Cisplatin (30 mg/m² fixed dose on day 1), S-1 (40-60 mg/day fixed dose twice a day for 7 days), every 2 weeks until progression
Trial: 21552482
Drug: Guided internet
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided internet self-help treatment program (22 patients)
Trial: 19940609
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day laropiprant
Trial: 11513787
Drug: Combination gloves
RxNorm normalized name: GLOVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination gloves
Trial: 9096447
Drug: rHuEPO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO therapy for 6 months in group I (n = 20)
Trial: 9096447
Drug: rHuEPO therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO therapy and iron supplement in group II (n = 20)
Trial: 8502627
Drug: Single 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 800 mg dose of pefloxacin
Trial: 8502627
Drug: 10 days'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days' course of norfloxacin 400 mg bid
Trial: 3573825
Drug: Calcium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium infusion (2 mg/kg over 5 minutes)
Trial: 26971081
Drug: Sertraline 200
RxNorm normalized name: sertraline 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 200 mg/day
Trial: 27659276
Drug: 5% benzocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% benzocaine gel
Trial: 24100112
Drug: H pylori
RxNorm normalized name: Helicobacter pylori
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H pylori eradication therapy (20 mg omeprazole, 1 g amoxicillin, and 500 mg clarithromycin twice daily for 1 week)
Trial: 10872661
Drug: H pylori
RxNorm normalized name: Helicobacter pylori
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H pylori eradication therapy
Trial: 22662132
Drug: Topical insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical insulin cream
Trial: 20137365
Drug: 30‐minute formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30‐minute formula electro‐acupuncture treatment
Trial: 15583944
Drug: Potentiometric immunosensor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potentiometric immunosensor for adrenal cortical hormones (ACH)
Trial: 9521952
Drug: Ciprofloxacin oral
RxNorm normalized name: ciprofloxacin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin oral suspension (10 mg/kg body weight, three times daily)
Trial: 7570860
Drug: Preventive therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive therapy for tuberculosis
Trial: 22633265
Drug: GnRH antagonists
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonists
Trial: 27871928
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg daily for 6 months
Trial: 18398457
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atorvastatin daily
Trial: 25769003
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg atorvastatin daily
Trial: 25769003
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose atorvastatin
Trial: 23826798
Drug: Multidimensional Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidimensional Treatment Foster Care for Preschoolers
Trial: 17083766
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of methotrexate (MTX), sulfasalazine (SSZ), hydroxychloroquine (HCQ), and prednisolone
Trial: 15305885
Drug: Intralipid with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid with heparin
Trial: 10708327
Drug: Community-based drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based drug prevention, education, and treatment projects providing case management and referral to services or day treatment
Trial: 8507346
Drug: MDE (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDE (140 mg)
Trial: 27500639
Drug: DNA prime-recombinant
RxNorm normalized name: somatropin (recombinant DNA origin)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNA prime-recombinant adenovirus 5 (rAd5) boost HIV vaccine
Trial: 24377454
Drug: Pistachio nuts
RxNorm normalized name: Pistachio nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pistachio nuts (20% energy daily)
Trial: 22592096
Drug: 0.5-1.0 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5-1.0 µg calcitriol and 1200 IU (30 µg) cholecalciferol
Trial: 22592096
Drug: Changes in
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Canges XP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Changes in parathyroid hormone
Trial: 18678155
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) at Shuigou (GV 26) plus western medicine
Trial: 18630533
Drug: Simple western
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple western medicine
Trial: 10367592
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg, n = 11)
Trial: 10367592
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitors (n = 11)
Trial: 1677361
Drug: Clonidine (0.300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.300 mg, orally) and Pyridostigmine (120 mg, orally)
Trial: 1677361
Drug: Atropine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (1 mg, im)
Trial: 1677361
Drug: Atropine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (1 mg, im) and Clonidine (0.300 mg, orally)
Trial: 1677361
Drug: Yohimbine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (30 mg, orally)
Trial: 6342357
Drug: Coingestion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coingestion of 50 g fat (butter) with 50 g carbohydrate (potato)
Trial: 6342357
Drug: Coingestion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coingestion of 50 g fat (butter) with 50 g protein (low fat veal)
Trial: 31237182
Drug: Electroconvulsive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroconvulsive therapy (ECT) after four treatments
Trial: 29987144
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of Naphthoquine-Azithromycin (NQAZ)
Trial: 29987144
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of Naphthoquine-Azithromycin (NQAZ)
Trial: 16618270
Drug: Olmesartan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan (10 to 40 mg)
Trial: 17210069
Drug: ATP infusions
RxNorm normalized name: ATP
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATP infusions with usual palliative care and dietetic advice
Trial: 9583926
Drug: Levodopa and
RxNorm normalized name: levodopa and decarboxylase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa and a dopa decarboxylase inhibitor in combination with selegiline (arm 2)
Trial: 9583926
Drug: Levodopa and
RxNorm normalized name: levodopa and decarboxylase inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa and a dopa carboxylase inhibitor (arm 1)
Trial: 2696670
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg intravitreal 5-FU
Trial: 22440491
Drug: Tirofiban 25
RxNorm normalized name: tirofiban 250 mcg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban 25 μg/kg bolus
Trial: 22440491
Drug: Tirofiban bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban bolus with post-bolus 2-h infusion
Trial: 21053455
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids and beta2 agonists for eight weeks (Group A)
Trial: 21053455
Drug: Oral beta2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral beta2 agonists only for eight weeks (Group B)
Trial: 7843758
Drug: Lisinopril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (10 mg)
Trial: 10421037
Drug: Cefazolin-oxacillin combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin-oxacillin combination (group C, 300 patients)
Trial: 2205964
Drug: Naltrexone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (25 mg on the first day, then 50 mg daily)
Trial: 6444678
Drug: Topical program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical program of tretinoin, benzoyl peroxide, and water avoidance
Trial: 6444678
Drug: Systemic tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic tetracycline therapy with abradant cleansers
Trial: 6444678
Drug: Systemic tetracycline
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic tetracycline therapy with topically applied tretinoin
Trial: 6444678
Drug: Topical program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical program
Trial: 31977842
Drug: Letrozole (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (5.0 mg/d on days 3-5 of menstrual cycle for 5 days)
Trial: 31977842
Drug: Human Menopausal
RxNorm normalized name: Human menopausal gonadotropin
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human Menopausal Gonadotropin (75 U/d intramuscular injection starting from day 3 of menstrual cycle for 5 days)
Trial: 23111014
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound dressing treatment (Prevena, KCI, Wiesbaden, Germany) with -125 mm Hg for 6 to 7 days
Trial: 23111014
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound dressing treatment
Trial: 19296295
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving only antipsychotics
Trial: 8943580
Drug: Cocaine treatment
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine treatment trial
Trial: 1742266
Drug: 10% solution
RxNorm normalized name: Mucomyst 10% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% solution of povidine-iodine for pre-operative skin preparation
Trial: 1742266
Drug: No skin
RxNorm normalized name: Aveeno Skin Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No skin preparation (control group)
Trial: 6128012
Drug: Org NC
RxNorm normalized name: ORG NC 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Org NC 45 (0.1 mg kg‐1)
Trial: 8904256
Drug: Pancuronium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium (0.1 mg kg‐1)
Trial: 28493510
Drug: Rocuronium 0.45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.45 mg.kg‐1 with neostigmine (50 μg.kg‐1 with glycopyrrolate 10 μg.kg‐1)
Trial: 28493510
Drug: Rocuronium 0.90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.90 mg.kg‐1 with sugammadex (4 mg.kg‐1)
Trial: 22451244
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of 5 mg oxycodone hydrochloride
Trial: 22451244
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution of 5 mg oxycodone hydrochloride
Trial: 22451244
Drug: Capsule of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule of 5 mg oxycodone hydrochloride
Trial: 22451244
Drug: Controlled-release tablet
RxNorm normalized name: ALAmax CR Controlled-Release Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release tablet of 5 mg oxycodone hydrochloride
Trial: 20965827
Drug: Pulsed magnetic
RxNorm normalized name: MAGNESIA
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsed magnetic field treatment (20-40 mT, 50 Hz, 20 min per time, 1 time per day for 14 days)
Trial: 9872822
Drug: Inhaled formoterol
RxNorm normalized name: formoterol Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled formoterol (Foradil) 24 microgram, twice a day for 8 weeks
Trial: 9872822
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 400 microgram, twice a day for 8 weeks
Trial: 9872822
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo inhaled twice a day for 8 weeks
Trial: 7720758
Drug: Captopril 12.5-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 12.5-50 mg per day (divided in 2-3 doses) p.o. in addition to 'conventional' therapy with digoxin and diuretics
Trial: 7720758
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy only (control group)
Trial: 1827043
Drug: Betaxolol, furosemide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol, furosemide, and minoxidil combination
Trial: 30765298
Drug: Electronic reminders
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic reminders (weekly messages based on behavioral psychology principles)
Trial: 29929537
Drug: Risperidone (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (up to 4 mg orally)
Trial: 27090728
Drug: Analgesic pharmacotherapy
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesic pharmacotherapy
Trial: 24108527
Drug: Galsulfase 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galsulfase 1.0 mg/kg/week
Trial: 24108527
Drug: Galsulfase 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galsulfase 2.0 mg/kg/week
Trial: 24108527
Drug: Galsulfase 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galsulfase 1.0 mg/kg/week and 2.0 mg/kg/week
Trial: 19556526
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with overground gait training only (n=45)
Trial: 21914118
Drug: Transforaminal (TF)
RxNorm normalized name: transforming growth factor beta 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transforaminal (TF) epidural steroid injection
Trial: 17456677
Drug: Caudal (C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal (C) epidural steroid injection
Trial: 8885803
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aqueous nasal spray (220 micrograms/day)
Trial: 1333781
Drug: Celiprolol 200
RxNorm normalized name: celiprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol 200 mg (C200)
Trial: 1333781
Drug: Celiprolol 400
RxNorm normalized name: celiprolol 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol 400 mg (C400)
Trial: 1333781
Drug: Celiprolol 800
RxNorm normalized name: celiprolol
DrugBank: Celiprolol (DB04846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol 800 mg (C800)
Trial: 6724256
Drug: chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chenodeoxycholic acid (1 g/day)
Trial: 6724256
Drug: ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ursodeoxycholic acid (1 g/day)
Trial: 21576829
Drug: Non-ARB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ARB treatment
Trial: 16080838
Drug: High-dose glucose-insulin-potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose glucose-insulin-potassium (GIK) infusion for 24 hours
Trial: 9667263
Drug: More intensive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More intensive preoperative chemotherapy regimen (two courses of cisplatin and doxorubicin in addition to high‐dose methotrexate and bleomycin, cyclophosphamide, and dactinomycin)
Trial: 9667263
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (therapy based on the T10 protocol)
Trial: 9667263
Drug: More intensive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More intensive preoperative chemotherapy regimen
Trial: 8138256
Drug: Interferon-alpha treatment
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha treatment for 4 months
Trial: 28270726
Drug: Acupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture therapy (30 minutes daily for 2 weeks)
Trial: 20137437
Drug: Intradiscal injection
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradiscal injection of diprospan (compound betamethasone) 3 ml (B group)
Trial: 20137437
Drug: Interventional injection
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interventional injection of diprospan (compound betamethasone) 1 ml + songmeile (cervus & cucumis polypeptide injection) 2 ml (C group)
Trial: 20137437
Drug: Intradiscal injection
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradiscal injection of normal saline 3 ml (A group, control)
Trial: 18075283
Drug: Acute insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute insulin infusion (euglycemic hyperinsulinemic clamp)
Trial: 15007248
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy in locally advanced gastric cancer